[
  {
    "ts": null,
    "headline": "This ETF Is Proof That the Healthcare Rebound Is Real",
    "summary": "Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.",
    "url": "https://finnhub.io/api/news?id=37f4d5b38f1ff502010ff587add70bfce19fea47b3f9d689eddcb7adcf089fbb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768147380,
      "headline": "This ETF Is Proof That the Healthcare Rebound Is Real",
      "id": 138075157,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.",
      "url": "https://finnhub.io/api/news?id=37f4d5b38f1ff502010ff587add70bfce19fea47b3f9d689eddcb7adcf089fbb"
    }
  }
]